Zhigui Cai

机构：Xijing Hospital

发表论文 9 篇 · 总被引 31 次 · h-index 4

代表论文

• Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial (2024 · BMC Infectious Diseases · 被引 11)
• Resistive spontaneous breathing exacerbated lipopolysaccharide-induced lung injury in mice (2024 · Biochemistry and Biophysics Reports · 被引 5)
• Patient self-inflicted lung injury associated pneumothorax/pneumomediastinum is a risk factor for worse outcomes of severe COVID-19: a case-control study (2024 · Scientific Reports · 被引 4)
• CLCA1 exacerbates lung inflammation via p38 MAPK pathway in acute respiratory distress syndrome (2024 · Experimental Lung Research · 被引 4)
• Nirmatrelvir/ritonavir reduced mortality in severe or critical COVID-19 patients: a multicenter retrospective cohort study (2026 · Frontiers in Medicine · 被引 2)
• Harnessing NLRX1: a new frontier in mitigating inflammation in pulmonary hypertension (2025 · Respiratory Research · 被引 2)